Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raymond Taeyong Chung, M.D.


This page shows the publications co-authored by Raymond Chung and Darrick Li.
Connection Strength

  1. Overview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus. Methods Mol Biol. 2019; 1911:3-32.
    View in: PubMed
    Score: 0.795
  2. Use of proton pump inhibitors in chronic liver diseases. Clin Liver Dis (Hoboken). 2017 Dec; 10(6):148-151.
    View in: PubMed
    Score: 0.742
  3. Reply to antiviral therapy and hepatocellular carcinogenesis. Cancer. 2016 Jan 01; 122(1):158.
    View in: PubMed
    Score: 0.633
  4. Reply to direct-acting antiviral drugs and hepatitis C virus: A therapeutic revolution? Cancer. 2015 Dec 01; 121(23):4269-70.
    View in: PubMed
    Score: 0.629
  5. Impact of hepatitis C virus eradication on hepatocellular carcinogenesis. Cancer. 2015 Sep 01; 121(17):2874-82.
    View in: PubMed
    Score: 0.622
  6. No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis. Hepatoma Res. 2019; 5.
    View in: PubMed
    Score: 0.207
  7. The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study. Hepatology. 2018 06; 67(6):2244-2253.
    View in: PubMed
    Score: 0.189
  8. Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement. PLoS One. 2019; 14(5):e0217442.
    View in: PubMed
    Score: 0.051
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.